US Broker Ratings

Medtronic plc (MDT) Investor Outlook: A Healthcare Giant with a Promising Upside

Medtronic plc (NYSE: MDT) stands as a prominent player in the healthcare sector, specifically within the medical devices industry. With its headquarters in Galway, Ireland, Medtronic’s expansive reach and innovative..

Illumina, Inc. (ILMN) Stock Analysis: Navigating the Genomics Giant’s 9.40% Revenue Growth amid Volatility

Illumina, Inc. (NASDAQ: ILMN) has positioned itself as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in San Diego, California, Illumina specializes in..

Oscar Health, Inc. (OSCR) Stock Analysis: Exploring the 70% Revenue Growth in Healthcare

Oscar Health, Inc. (NYSE: OSCR) has become a noteworthy player in the healthcare sector, standing out in the healthcare plans industry with an impressive market capitalization of $9.89 billion. This..

Guardant Health, Inc. (GH) Stock Analysis: A Promising Growth Potential with Strong Buy Ratings

Guardant Health, Inc. (NASDAQ: GH) stands at the forefront of precision oncology, providing innovative blood and tissue tests that are reshaping the landscape of cancer diagnostics. Headquartered in Palo Alto,..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: Strong Buy Ratings and Impressive 10.65% Upside Potential

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology industry, continues to capture investor attention with its robust portfolio of innovative pharmaceutical products. With a market capitalization of..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Exploring a 8.03% Potential Upside in the Healthcare Sector

Bausch + Lomb Corporation (NYSE: BLCO), a stalwart in the healthcare sector with a market capitalization of $6.16 billion, is carving out its niche in the medical instruments and supplies..

BioNTech SE (BNTX) Stock Analysis: Navigating a 4.14% Upside Amidst Revenue Challenges

BioNTech SE (NASDAQ: BNTX), a prominent player in the biotechnology sector known for its groundbreaking mRNA technologies, is currently trading at $116.57, near the upper end of its 52-week range..

Moderna, Inc. (MRNA) Stock Analysis: Navigating a 37% Downside in Biotech’s Dynamic Future

Moderna, Inc. (NASDAQ: MRNA) has become a prominent name in the biotechnology sector, primarily known for its groundbreaking work in messenger RNA (mRNA) technology. As the biotech giant continues to..

McKesson Corporation (MCK) Stock Analysis: A Healthcare Giant with a 14.91% Upside Potential

McKesson Corporation (NYSE: MCK), a stalwart in the healthcare sector, is capturing the attention of investors with its robust market presence and promising growth potential. As a leader in medical..

Alcon Inc. (ALC): Investor Outlook on Its 15.77% Potential Upside

Alcon Inc. (NYSE: ALC), a heavyweight in the medical instruments and supplies sector, continues to draw investor attention with its promising growth potential. Specializing in eye care products, Alcon operates..

Alkermes plc (ALKS) Investor Outlook: Analyzing 15.87% Potential Upside in the Biopharma Sector

Alkermes plc (NASDAQ: ALKS), a prominent player in the biopharmaceutical space, has recently caught the attention of investors aiming to capitalize on healthcare innovations. Headquartered in Dublin, Ireland, Alkermes has..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Report: Analysts See 31% Upside Potential with Strong Buy Ratings

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is capturing the attention of investors with its promising position in the biotechnology sector, particularly in the treatment of metabolic dysfunction-associated steatohepatitis (MASH). With a..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Capturing 10% Upside Potential with Innovative Medical Devices

GE HealthCare Technologies Inc. (NYSE: GEHC), a prominent player in the healthcare sector, commands a market capitalization of $33.8 billion. With its roots in the development, manufacturing, and marketing of..

Elanco Animal Health (ELAN) Stock Analysis: Unlocking a 30% Upside Potential with Strong Buy Ratings

Elanco Animal Health Incorporated (NYSE: ELAN) is making waves in the healthcare sector, specifically within the realm of drug manufacturing for specialty and generic animal health products. With a market..

The Ensign Group, Inc. (ENSG) Stock Analysis: A Strong Healthcare Contender with 22.58% Potential Upside

The Ensign Group, Inc. (NASDAQ: ENSG) is making waves in the healthcare sector, particularly in the medical care facilities industry. With a market capitalization of $10.46 billion, Ensign is carving..

argenx SE (ARGX) Stock Analysis: Unpacking the 12.79% Potential Upside in Biotech Innovation

argenx SE (NASDAQ: ARGX), a trailblazer in the biotechnology sector, is capturing investor attention with its promising therapeutic pipeline and robust market performance. Based in the Netherlands and operating globally,..

Universal Health Services, Inc. (UHS) Stock Analysis: Evaluating a 9.41% Potential Upside Amid Healthcare Growth

Universal Health Services, Inc. (NYSE: UHS) stands as a prominent player in the healthcare sector, specializing in medical care facilities across the United States. With a market capitalization of $10.45..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a 29.47% Potential Upside

United Therapeutics Corporation (NASDAQ: UTHR) stands prominently in the healthcare sector as a leader among specialty and generic drug manufacturers. With a market capitalization of $22.01 billion, this biotech giant..

Summit Therapeutics Inc. (SMMT): Growth Potential and Analyst Consensus with 117.45% Upside

Summit Therapeutics Inc. (NASDAQ: SMMT) stands as a noteworthy player in the biotechnology sector, specializing in the discovery and development of innovative therapies aimed at addressing unmet medical needs. With..

West Pharmaceutical Services (WST) Stock Analysis: Riding a 14.63% Potential Upside with Strong Analyst Confidence

West Pharmaceutical Services, Inc. (NYSE: WST) continues to capture investor attention with its solid positioning in the healthcare sector, specifically within the medical instruments and supplies industry. With a market..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds